Alpine Immune Sciences

Alpine Immune Sciences, established in 2015, is dedicated to the development of innovative immunotherapies for treating inflammatory and autoimmune diseases as well as cancer. The company employs advanced protein engineering techniques, including a directed evolution platform, to create novel immune proteins. Alpine has a diverse and robust development pipeline, with multiple product candidates currently undergoing clinical trials. The company has also established collaborations with leading global partners to enhance its research and development capabilities. Alpine Immune Sciences is headquartered at 188 East Blaine Street, Suite 200, Seattle, WA, in the biotech-centric neighborhood of Eastlake. The company supports its employees with a competitive benefits package that includes premium medical, dental, and vision coverage, flexible paid time off, equity participation, and hybrid work options equipped with state-of-the-art collaboration tools.